Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2025-07-03 00:00:00 ET · period of report 2025-07-01 · accession 0001415889-25-019382 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | PMVP | Carulli Michael | CFO | S - Sale | $1.06 | -28.2K | 60.1K | -32% | -$29.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 28,249 | $1.06 | 60,146 | D | — | — | (F1) The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. |